|Table of Contents|

Research progress on the prediction of lymph node metastasis risk by pathological factors of conization specimens of early-stage cervical cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 11
Page:
2161-2163
Research Field:
Publishing date:

Info

Title:
Research progress on the prediction of lymph node metastasis risk by pathological factors of conization specimens of early-stage cervical cancer
Author(s):
YU Ting; LI Zhiwei; LIU Sha; JIANG Jiyong
Dalian Obstetrics and Gynecology Hospital Affiliated to Dalian Medical University，Liaoning Dalian 116033，China.
Keywords:
uterine cervical neoplasms; lymph node; conization
PACS:
R737.33
DOI:
10.3969/j.issn.1672-4992.2023.11.034
Abstract:
Lymph node metastasis(LNM) is one of the high-risk factors affecting the prognosis of patients with cervical cancer,and the survival rate of those with LNM positive is significantly reduced,as the International Federation of Obstetrics and Gynecology(FIGO 2018) has included LNM status in the disease staging.Most of the studies are based on the pathological factors of radical hysterectomy(RH) specimens to analyze the LNM risk factors of cervical cancer.However,there are few literatures on whether the LNM status can be predicted before radical surgery.The purpose of this review was to retrieve the relevant literature on the relationship between pathological factors of conization specimens and LNM in patients with early-stage cervical cancer,and to analyze and summarize,with the aim to find out the factors related to LNM before RH of early-stage cervical cancer and analyze their clinical significance in predicting the risk of LNM of early-stage cervical cancer.

References:

[1]TORRE LA,ISLAMI F,SIEGEL RL,et al.Global cancer in women:burden and trends［J］.Cancer Epidemiol Biomarkers Prev,2017,26(4):444-457.
[2]MATSUO K,MACHIDA H,MANDELBAUM RS,et al.Validation of the 2018 FIGO cervical cancer staging system［J］.Gynecol Oncol,2019,152(1):87-93.
[3]GRAVES S,SEAGLE BLL,STROHL AE,et al,Survival after pelvic exenteration for cervical cancer:a national cancer database study［J］.Int J Gynecol Cancer，2017，27(2):390-395.
[4]WANG Y,YAO T,YU J,et al.Can pelvic lymphadenectomy be omitted in patients with stage IA2,IB1 and IIA1 squamous cell cervical cancer［J］.Springer Plus,2016,5(1):1262.
[5]JAMSET I,HANPRASERTPONG J.Risk factors for parametrial involvement in early-stage cervical cancer and identification of patients suitable for less radical surgery［J］.Oncol Res Treat,2016,39(7-8):432-438.
[6]周滢,姜继勇.早期宫颈癌淋巴脉管间隙浸润与临床病理因素及预后的关系［J］.实用妇产科杂志，2018，34(3):203-207. ZHOU Y,JIANG JY.Relationship among lymph vascular space invasion with clinicopathological factors and prognosis in early cervical cancer［J］.Journal of Practical Obstetrics and Gynecology,2018，34(3):203-207.
[7]NANTHAMONGKOLKUL K,HANPRASERTPONG J.Predictive factors of pelvic lymph node metastasis in early-stage cervical cancer［J］.Oncol Res Treat,2018,41(4):194-198.
[8]MINIG L,FAGOTTI A,SCAMBIA G,et al.Incidence of lymph node metastases in women with low-risk early cervical cancer(<2 cm) without lymph-vascular invasion［J］.Int J Gynecol Cancer,2018,28(4):788-793.
[9]KODAMA J,KUSUMOTO T,NAKAMURA K,et al.Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery［J］.Gynecologic Oncology,2011,122(4):491-494.
[10]HUTCHCRAFT ML，SMITH B，MCLAUGHLIN，et al.Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer［J］.Gynecol Oncol,2019,153(2):255-258.
[11]FERRANDINA G,PEDONE ANCHORA L,GALLOTTA V,et al.Can we define the risk of lymph node metastasis in early-stage cervical cancer patients? A large-scale,retrospective study［J］.Ann Surg Oncol,2017,24(8):2311-2318.
[12]MILAM MR,FRUMOVITZ M,DOS REIS R,et al.Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer［J］.Gynecol Oncol,2007,106(1):12-15.
[13]CHANDACHAM A,CHAROENKWAN K,SIRIAUNKGUL S.Extent of lymphovas- cular space invasion and risk of pelvic lymph node metastases in stage Ⅰb1 cervical cancer［J］.J Med Assoc Thai,2005,88(2):S31-S36.
[14]POL FJ,ZUSTERZEEL PL,VAN HAM MA,et al.Satellite lymphovascular space invasion:an independent risk factor in early stage cervical cancer［J］.Gynecologic Oncology,2015,138(3):579－584.
[15]LEE KB，LEE JM，PARK，et al.Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix［J］.Int J Gynecol Cancer，2006，16(3):1184-1187.
[16]MI-KYUNG KIM,JAE WEON KIM,MIN A KIM,et al.Feasibility of less radical surgery for superficially invasive carcinoma of the cervix［J］.Gynecol Oncol,2010,119(2):187-191.
[17]陈刚,张兴旺.早期宫颈癌患者的临床病理特征及淋巴结转移的相关因素分析［J］.临床医学研究与实践,2019,4(24):136-138. CHEN G,ZHANG XW.Analysis of clinicopathological characteristics and related factors of lymph node metastasis in patients with early cervical cancer［J］.Clinical Research and Practice,2019,4(24):136-138.
[18]TOGAMI S,KAMIO M,YANAZUME S,et al.Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer［J］.Int J Gynecol Cancer,2014,24(6):1072-1076.
[19]GULSEREN V,KOCAER M,GUNGORDUK O,et al.Preoperative predictors of pelvic and para-aortic lymph node metastases in cervical cancer［J］.J Can Res Ther,2019,15(6):1231-1234.
[20]AL-KALBANI M,MCVEIGH G,NAGAR H,et al.Do FIGO stage IA and small(≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery［J］.Int J Gynecol Cancer,2012,22(2):291-295.
[21]YE S,SUN X,KANG B,et al.The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay:a prospective observational study［J］.BMC Cancer,2020,20(1):138.
[22]刘娟,冉立.SCC-Ag在宫颈癌中应用的研究进展［J］.现代肿瘤医学,2022,30(02):326-329. LIU J,RAN L.The research progress of application of SCC-Ag in cervical cancer［J］.Modern Oncology,2022,30(02):326-329.
[23]YAN L,YAO H,LONG R,et al.A preoperative radiomics model for the identification of lymph node metastasis in patients with early-stage cervical squamous cell carcinoma［J］.Br J Radiol,2020,93(1116) :20200358.
[24]GAARENSTROOM KN,KENTER GG,BONFRER JM,et al.Can initial serum cyfra 21-1,SCC antigen,and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis［J］.Gynecol Oncol,2000,77(1):164-170.
[25]SUN JR,ZHANG YN,SUN XM,et al.Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value［J］.Minerva Chir,2011,66(6):537-545.
[26]CHEN JY,YAO DS,WU ZJ,et al.Diagnostic value of serum squamous cell carcinoma antigen on lymphatic metastasis in cervical cancer:a meta-analysis［J］.Cancer Research on Prevention and Treatment,2012,39(7):811-817.
[27]JOEHLIN-PRICE AS,STEPHENS JA,ZHANG J,et al.Endometrial cancer insulin-like growth factor 1 receptor(IGF1R) expression increases with body mass index and is associated with pathologic extent and prognosis［J］.Cancer Epidemiol Biomarkers Prev,2016,25(3):438-445.
[28]WU C,WANG L,CHEN W,et al.Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer:a retrospective study［J］.Medicine(Baltimore),2017,96(9):e6202.
[29]ACHOURI A,HUCHON C,BATS AS,et al.Complications of lymphadenectomy for gynecologic cancer［J］.Eur Surg Oncol,2013,39(1):81-96.
[30]DESSOURCES K,AVIKI E,LEITAO MM.Lower extremity lymphedema in patients with gynecologic malignancies［J］.Int J Gynecol Cancer,2020,30(2):252-260.

Memo

Memo:
-
Last Update: 2023-04-28